Beurs.nl monitor iconMarkt Monitor
  • AEX +0,32 819,56 +0,04%
  • DE40 -188,63 20.374,10 -0,92%
  • US500^ 0,00 5.358,26 0,00%
  • US30^ 0,00 40.214,00 0,00%
  • EUR/USD 0,00 1,1351 -0,08%
  • WTI 0,00 61,48 0,00%
  • Gold spot +62,24 3.237,46 +1,96%

Brunel 2019

1.703 Posts
Pagina: «« 1 ... 12 13 14 15 16 ... 86 »» | Laatste | Omlaag ↓
  1. forum rang 4 groene appel 13 februari 2019 15:18
    11-02-2019 Brunel International N.V. (AMS:BRNL), which is in the professional services business, and is based in Netherlands, saw a double-digit share price rise of over 10% in the past couple of months on the ENXTAM. As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Let’s examine Brunel International’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

    See our latest analysis for Brunel International

    What is Brunel International worth?
    According to my relative valuation model, the stock is currently overvalued. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that Brunel International’s ratio of 50.71x is above its peer average of 17.77x, which suggests the stock is overvalued compared to the Professional Services industry. If you like the stock, you may want to keep an eye out for a potential price decline in the future. Given that Brunel International’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

    What does the future of Brunel International look like?
    ENXTAM:BRNL Future Profit February 11th 19
    ENXTAM:BRNL Future Profit February 11th 19
    More
    Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations. With profit expected to more than double over the next couple of years, the future seems bright for Brunel International. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

    What this means for you:
    Are you a shareholder? BRNL’s optimistic future growth appears to have been factored into the current share price, with shares trading above its fair value. However, this brings up another question – is now the right time to sell? If you believe BRNL should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

    Are you a potential investor? If you’ve been keeping tabs on BRNL for some time, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for BRNL, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.

    Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Brunel International. You can find everything you need to know about Brunel International in the latest infographic research report. If you are no longer interested in Brunel International, you can use our free platform to see my list of over 50 other stocks with a high growth potential.
  2. BASF en BAYER kopen 13 februari 2019 15:26
    quote:

    rode appel schreef op 13 februari 2019 15:21:

    van Yahoo door Jodi Pearce
    Simply Wall St.February 11, 2019
    Wat een suf gewauwel zeg van die Jodi, wat een fake report . Typisch iemand die de klok heeft horen luiden maar niet weet waar de klepel hangt.

    [Modbreak IEX: Gelieve elkaar niet persoonlijk aan te vallen, bericht is bij dezen aangepast.]
  3. forum rang 4 groene appel 13 februari 2019 15:30
    quote:

    jaar2018 schreef op 13 februari 2019 15:26:

    [...]

    Wat een suf gewauwel zeg van die Jodi, wat een fake report . Typisch iemand die de klok heeft horen luiden maar niet weet waar de klepel hangt.
    we zitten gelukkig alweer op de 13de en hebben we de verwachtingen van de ING en ABN al voorbij zien komen....
  4. forum rang 5 maci 13 februari 2019 16:12
    quote:

    rode appel schreef op 13 februari 2019 15:30:

    [...]

    we zitten gelukkig alweer op de 13de en hebben we de verwachtingen van de ING en ABN al voorbij zien komen....
    En toch vond je het nodig om dat artikel te plaatsen nadat ik het artikel van heden had gepost.
    Vreemde gewaarwording!
  5. forum rang 4 groene appel 13 februari 2019 16:24
    was dat artikel dan al geplaatst? zo kun je mooi verschillende inzichten en belangen naast elkaar leggen en voor jezelf kijken wie wat zegt en waarom iemand dat plaatst, was enkel bedoeld om dat artikel tegen het licht te houden naast dat die van jouw wat een veel mooiere inhoud had.
1.703 Posts
Pagina: «« 1 ... 12 13 14 15 16 ... 86 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beurs.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.163
AB InBev 2 5.544
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.507
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.931
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 193
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.892
Aedifica 3 927
Aegon 3.258 323.213
AFC Ajax 538 7.093
Affimed NV 2 6.306
ageas 5.844 109.909
Agfa-Gevaert 14 2.074
Ahold 3.538 74.363
Air France - KLM 1.025 35.331
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.072
Alfen 16 25.503
Allfunds Group 4 1.525
Almunda Professionals (vh Novisource) 651 4.252
Alpha Pro Tech 1 17
Alphabet Inc. 1 427
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 244.271
AMG 972 134.761
AMS 3 73
Amsterdam Commodities 305 6.757
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 501
Antonov 22.632 153.605
Aperam 92 15.106
Apollo Alternative Assets 1 17
Apple 5 387
Arcadis 252 8.808
Arcelor Mittal 2.035 321.097
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.380
Aroundtown SA 1 221
Arrowhead Research 5 9.759
Ascencio 1 30
ASIT biotech 2 697
ASMI 4.108 39.700
ASML 1.767 112.331
ASR Nederland 21 4.522
ATAI Life Sciences 1 7
Atenor Group 1 523
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 14.350
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.463